ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TILS Tiziana Life Sciences Plc

58.50
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tiziana Life Sciences Plc LSE:TILS London Ordinary Share GB00BKWNZY55 ORD 3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 58.50 45.00 60.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Tiziana Life Sciences Share Discussion Threads

Showing 476 to 497 of 17925 messages
Chat Pages: Latest  21  20  19  18  17  16  15  14  13  12  11  10  Older
DateSubjectAuthorDiscuss
11/6/2018
20:10
Not really, jpuff. A lot of us TILS holders became so only because were unfortunate enough to have been in RGT - especially genises.
asmodeus
11/6/2018
16:35
For any Rgt holders tap news in the epic and also search on google colostrinin images
You will find a new supplier for USA and Europe

genises
07/6/2018
17:03
What a massive disappointment this has become over the past year. Feel totally let down by the abysmal share price performance.
jpuff
23/5/2018
14:25
Hmm now what's going on? -31%
jpuff
27/4/2018
14:58
No trades at all here no matter how low the price is. We either need some news to get it noticed or else I fear it will fade still further into obscurity and the abyss.
jpuff
27/4/2018
08:03
See what I mean, lol
stenick
27/4/2018
07:12
Lol Asmodeus, predictive text.
Daicaprice, I’m expecting lots of news here over the next couple of months as they have said.
Oral foralumab trial news,nasal foralumab IND applied for,Milciclib trial with soranafib (Bayer drug) starting, and application for marketing Licence for Milciclib. All these they have said they are aiming for. I am monitoring the FDA and EMA sites as they list all new applications for drugs.
But as you probably know already that AIM companies do not always go well as expected.
They have raised a lot of money recently, from £1.50p to 80p, and of course the tax rebates that will amount to about £3mill, so l hope no more fund raising will occur.
Your Call. Good luck all

stenick
26/4/2018
21:31
I have a few here from £1.52, I have written them off but am tempted to get myself down to av £1. Any thoughts on my sanity and should I do so?

DC

daicaprice
26/4/2018
21:13
Yes - I used to hate PT - but it cured my Asthma :)
asmodeus
26/4/2018
07:25
Hi Stav
We did and I think we do have a chance of a return. 25p. To 240p to 80p and lots of ups and down in between is a traders dream surely. Nothing has changed they still have some potentially really good products, loads of money, and news to come, all with less than 150mill shares in issue. The crash and Beauforts going bust has not helped the share price I suspect.
I’m still hopeful here as I like what I hear about Milciclib and the thought of using a nasal spray to combat auto immune dieseas’s is appealing to me let alone big pharma. I’ve recouped some losses and hope for a bit more here.
Anyway nice to hear from you Stav hope your ok.

stenick
26/4/2018
07:20
Yes- still here, and still hopeful of getting something back. Percy taught me one important lesson (without intending to), and that was never to put too many eggs in one basket! So I am seriously diversified, and mainly in investment trusts, and this has produced adequate income and some capital gains post-Regen. How are you getting on, Stav?
asmodeus
25/4/2018
19:18
ASMO

Are you still here?

stav5001
25/4/2018
19:17
Hi Stenick

I thought we had a chance of getting something back here but its not looking good.

stav5001
19/4/2018
08:15
No comment either about the collapse in share price from 240p to 80p at a time when Beauforts put out a BUY recommendation at 200p+ .Mind you we are all aware of the circumstances surrounding Beauforts demise and we are looking to the FSCS to help out there. The whole saga stinks eh!
jpuff
19/4/2018
07:51
Pity existing loyal shareholders are now being diluted out of existence.
jpuff
16/4/2018
14:43
Nice RNS. I like that they mention Alzheimer’s. A lot going on. Shame about share price but I think that will change.
stenick
09/4/2018
10:40
Good RNS, am amazed with the results and safety profile of Milciclib it’s not on the market yet.Perhaps they are in collaboration with Bayer to see how their trial goes with sorafenib.
stenick
09/4/2018
07:53
The mm’s must have accumulated a lot of shares by now.
stenick
06/4/2018
21:21
And down again on yesterday's wonderful news :(
jpuff
05/4/2018
15:25
lol. Yes new broker, good news, no delisting :). Leopoldo hopefully will organise a strategy that gets the marketing licence for Milciclib and starts the trial with the Bayer drug,and starts the Foralumab trial.Or at least give us an update.
Things do take so long.

stenick
05/4/2018
08:15
At least we now have a new broker now. Also looks like the guy who bought the one share yesterday has panicked and sold it first thing this morning! ;)
jpuff
04/4/2018
12:40
1,000,000 would be a nicer buy Stenick :) but a good announcement today nonetheless.
jpuff
Chat Pages: Latest  21  20  19  18  17  16  15  14  13  12  11  10  Older

Your Recent History

Delayed Upgrade Clock